跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48,605 条关于
“oral small molecule degraders”
全部
48,605
临床试验
34,682
药物
1,834
机构
196
资讯
11,893
去年
Kymera Therapeutics Raises $250.8 Million to Advance Targeted Protein Degradation Pipeline
2年前
AstraZeneca Unveils Oral Small Molecule PCSK9 Inhibitor AZD0780
9个月前
Kymera Therapeutics Closes Upsized $602 Million Public Offering to Advance Targeted Protein Degradation Pipeline
去年
Immunic's Vidofludimus Calcium Shows Promise in Multiple Sclerosis Treatment
去年
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer to Advance Protein Degradation Platform
4年前
Sling Therapeutics Launches with $35M Series A Financing to Develop Oral Small Molecule for Thyroid Eye Disease
去年
Regor's Oral GLP-1RA RGT-075 Shows Promise in Phase 2a Obesity Trial
去年
IRA Impact: CDMOs Adapt to Navigate Small Molecule Drug Development Challenges
去年
Inavolisib Triples Progression-Free Survival in Advanced Breast Cancer
去年
Linsitinib Shows Promise in Reducing Proptosis in Thyroid Eye Disease
第 1 页，共 1190 页
上一页
下一页
